HighTower Advisors LLC Has $27,000 Stock Position in The Oncology Institute, Inc. (NASDAQ:TOI)

HighTower Advisors LLC grew its stake in The Oncology Institute, Inc. (NASDAQ:TOI) by 190.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 81,362 shares of the company’s stock after purchasing an additional 53,382 shares during the period. HighTower Advisors LLC owned approximately 0.11% of Oncology Institute worth $27,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, Tiff Advisory Services LLC raised its stake in Oncology Institute by 235.1% during the second quarter. Tiff Advisory Services LLC now owns 1,418,685 shares of the company’s stock worth $653,000 after acquiring an additional 995,280 shares in the last quarter. 36.86% of the stock is currently owned by institutional investors and hedge funds.

Oncology Institute Stock Up 19.0 %

Shares of NASDAQ TOI opened at $0.27 on Friday. The Oncology Institute, Inc. has a 52-week low of $0.13 and a 52-week high of $2.50. The company has a debt-to-equity ratio of 5.91, a quick ratio of 2.27 and a current ratio of 2.49. The business has a fifty day moving average of $0.24 and a two-hundred day moving average of $0.35. The stock has a market cap of $20.09 million, a PE ratio of -0.34 and a beta of 0.43.

Insider Buying and Selling

In related news, Director Brad Hively purchased 250,000 shares of Oncology Institute stock in a transaction that occurred on Tuesday, November 26th. The shares were acquired at an average price of $0.17 per share, for a total transaction of $42,500.00. Following the transaction, the director now directly owns 616,753 shares in the company, valued at approximately $104,848.01. This represents a 68.17 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 9.50% of the stock is currently owned by corporate insiders.

Oncology Institute Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.